des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists
- PMID: 1697594
des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists
Abstract
In the present study we examined the effect of carboxyl-terminal modifications of des-Met14-bombesin (Bn) on Bn receptor affinity in murine 3T3 cells, rat and guinea pig pancreatic acini, and the ability to initiate biologic responses by synthesizing 18 des-Met14-Bn(6-13) analogues. With guinea pig acini and 3T3 cells, affinity was affected by the chain length of the alkyl moiety (R) added to [D-Phe6]Bn(6-13)NH2R with relative potencies: propyl greater than ethyl greater than butyl = hexyl greater than heptyl greater than free amide, whereas in rat acini affinity was not increased by the chain length. In each cell system the affinity of the alkylamide was not increased by insertion of a phenyl group in the alkyl side chain, by making the analogue more neuromedin B-like or by addition of a reduced peptide bond. The affinity in each cell system was increased by additions of other electron releasing groups to the COOH-terminal carboxyl group such as [D-Phe6]Bn(6-13)ethyl or methyl ester, or hydrazide. In guinea pig pancreas and 3T3 cells, 12 analogues were antagonists, 1 a full and 5 partial agonists. In rat pancreas, 8 were antagonists, 5 full agonists, and 5 partial agonists. Potent antagonists in each cell system were the methyl and ethyl ester, hydrazide, and ethylamide analogues. In 3T3 cells or guinea pig pancreas, agonist activity of the alkylamide was critically dependent on the chain length, whereas with rat pancreatic Bn receptors any alkylamide longer than the ethylamide had agonist activity. In all three cell systems any alteration that made the alkylamide more neuromedin B-like caused agonist activity. These results demonstrate that the nature of the substitution on the carboxyl terminus of des-Met14-Bn analogues is critically important, not only for determining Bn receptor affinity, but also for determining the ability to initiate a biologic response. In contrast to previous studies, the present results demonstrate that the presence of the COOH-terminal amino acid in position 14 of Bn is not essential for initiating a biologic response. Several des-Met14-Bn analogues were potent partial agonists, whereas others such as the hydrazide or ethyl ester are very potent antagonists.
Similar articles
-
Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.Biochem J. 1992 Sep 1;286 ( Pt 2)(Pt 2):641-8. doi: 10.1042/bj2860641. Biochem J. 1992. PMID: 1326946 Free PMC article.
-
Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells.Biochemistry. 1990 Jan 23;29(3):616-22. doi: 10.1021/bi00455a004. Biochemistry. 1990. PMID: 1692477
-
Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.J Biol Chem. 1989 Sep 5;264(25):14691-7. J Biol Chem. 1989. PMID: 2475489
-
Systematic development of bombesin/gastrin-releasing peptide antagonists.J Natl Cancer Inst Monogr. 1992;(13):133-9. J Natl Cancer Inst Monogr. 1992. PMID: 1389686 Review.
-
Progress in the development of competitive bombesin antagonists.Ann N Y Acad Sci. 1988;547:150-7. doi: 10.1111/j.1749-6632.1988.tb23883.x. Ann N Y Acad Sci. 1988. PMID: 2467596 Review. No abstract available.
Cited by
-
Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.Biochem J. 1992 Sep 1;286 ( Pt 2)(Pt 2):641-8. doi: 10.1042/bj2860641. Biochem J. 1992. PMID: 1326946 Free PMC article.
-
Caveolin-1 suppresses human immunodeficiency virus-1 replication by inhibiting acetylation of NF-κB.Virology. 2012 Oct 10;432(1):110-9. doi: 10.1016/j.virol.2012.05.016. Epub 2012 Jun 28. Virology. 2012. PMID: 22748181 Free PMC article.
-
Bombesin receptor-mediated imaging and cytotoxicity: review and current status.Curr Drug Deliv. 2011 Jan;8(1):79-134. doi: 10.2174/156720111793663624. Curr Drug Deliv. 2011. PMID: 21034419 Free PMC article. Review.
-
The Nonpeptide Agonist MK-5046 Functions As an Allosteric Agonist for the Bombesin Receptor Subtype-3.J Pharmacol Exp Ther. 2022 Aug;382(2):66-78. doi: 10.1124/jpet.121.001033. Epub 2022 May 29. J Pharmacol Exp Ther. 2022. PMID: 35644465 Free PMC article.
-
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists.Pharmaceuticals (Basel). 2023 Apr 30;16(5):674. doi: 10.3390/ph16050674. Pharmaceuticals (Basel). 2023. PMID: 37242457 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous